SCAN Group Announces Formation of Diversification Advisory Council

Seasoned experts with experience across the healthcare ecosystem will support investment, acquisition and other strategies

LONG BEACH, Calif.--(BUSINESS WIRE)--SCAN Group, whose holdings include SCAN Health Plan, one of the nation’s largest not-for-profit Medicare Advantage plans, has tapped luminaries from the worlds of medicine, finance, technology and government for its Diversification Advisory Council. The newly formed group will offer guidance on how best to align with, grow and foster organizations that promote SCAN’s mission to support healthier aging.

“SCAN’s overall diversification strategy is rooted in building and partnering with the next generation of innovative organizations that share our mission to improve healthcare for older adults and keep them healthy and independent,” said Dr. Sachin Jain, president and CEO of SCAN Group and SCAN Health Plan. “The expert advisory council we’ve built will bring decades of experience to bear in support of that agenda.”

The inaugural members of SCAN’s Diversification Advisory Council include:

David Brailer, M.D., Ph.D.

Executive chairman, Health Evolution and former managing partner at HEP, a fund that invested in companies with the potential to transform health care delivery. Dr. Brailer was appointed by President George W. Bush as the nation’s first National Coordinator for Health Information Technology and was the founder and CEO of CareScience, for which he raised private and public capital in order to develop numerous solution and technology platforms.

Aneesh Chopra

President of CareJourney, an open data and analytics platform building a trusted, transparent rating system for physicians, networks, facilities and markets on the move to value. Mr. Chopra served as the first U.S. Chief Technology Officer and the fourth Virginia Secretary of Technology. A graduate of both the Harvard Kennedy School and The Johns Hopkins University, Mr. Chopra is an expert in public/private collaboration and is the author of Innovative State: How New Technologies can Transform Government.

Ana Gupte, Ph.D.

Strategy, finance and innovation leader and advisor with over two decades of experience in Healthcare Services and Digital Health. Most recently, Dr. Gupte served as SVP, chief strategy & innovation officer at Florida Blue and its parent company, GuideWell. She developed considerable expertise in equity research as a senior healthcare equity analyst at the Wall Street firms of SVB Leerink and Sanford C. Bernstein & Co., and was also managing director of Corporate Planning at Aetna, Inc.

Abby Miller Levy, M.B.A.

Managing partner and co-founder of Primetime Partners, a venture capital fund that invests in early stage companies that can transform the quality of living for older adults. Ms. Miller Levy has spent her career building brands across consumer products, media and health and wellness, most recently as the senior vice president of Strategy & Growth at SoulCycle and president of Thrive Global.

J. Mario Molina, M.D.

Healthcare entrepreneur, endocrinologist and philanthropist, best known for his tenure of over 20 years as chairman and chief executive officer of Molina Healthcare, a Fortune 200 company he and his family founded in the 1980’s. He is currently chairman of the board at United States of Care, and Adjunct Professor in the School of Global and Community Health at Claremont Graduate University. He has served on a variety of corporate and non-profit boards including those of Johns Hopkins Medicine and The Huntington Library.

Eric Topol, M.D.

Founder and director of the Scripps Research Translational Institute, professor of Molecular Medicine and executive vice-president of Scripps Research. Dr. Topol has published over 1,200 peer-reviewed articles, was elected to the National Academy of Medicine, and is one of the top 10 most cited researchers in medicine. Dr. Topol has received multi-million dollar grants from the NIH to lead several healthcare initiatives, and was the principal investigator for a flagship $35 million NIH grant to promote innovation in medicine. Dr. Topol has edited textbooks and published three bestsellers on the future of medicine. He was commissioned by the UK to lead planning for the National Health Service’s integration of AI and new technologies.

“When we put together this team, we didn’t just look for people who would give us advice—we sought a diverse group of seasoned experts who would share their experience,” said Binoy Bhansali, who leads Corporate Development for SCAN Group. “Our advisory team’s wisdom, combined with SCAN’s expertise in designing care for older adults, means SCAN is positioned to spur innovation that will improve and transform the delivery of healthcare for older Americans.”

The formation of the Diversification Advisory Council comes as SCAN accelerates its overall diversification and expansion efforts. In the past few months, SCAN has made investments in MedArrive, a healthcare logistics and services platform that enables payers and providers to extend care services into the home, and Monogram Health, a leading kidney care management company that provides in-home solutions for patients living with chronic kidney and end-stage renal disease.

SCAN will announce its next investment on Tuesday, October 19.